ARTICLE | Clinical News
Ecabet sodium: Preliminary Phase IIb data
February 27, 2006 8:00 AM UTC
ISTA reported preliminary results from a double-blind, placebo-controlled, U.S. Phase IIb trial in 162 patients that showed 3% ecabet (lower dose) led to a positive trend toward reducing symptoms of d...